Search For "dcgi"
Sputnik Light Covid vaccine gets permission for Phase 3 trials in
Updated : 1 week, 4 days ago IST
New Delhi [India], September 15 (ANI): The Drug Controller General of India has given its approval to the single-dose COVID-19 vaccine version of the Sputnik V vaccine 'Sputnik Light' to conduct trials on the Indian population to check whether the vaccine gives a similar immune response i
Read More
DCGI approves Hetero's Tocilizumab for treatment of COVID-19 in ho
Updated : 2 weeks, 6 days ago IST
Hyderabad (Telangana) [India], September 6 (ANI): Hetero announced on Monday that the Drug Controller General of India (DCGI) has approved Emergency Use Authorization (EUA) for its generic version of Tocilizumab in India for the treatment of COVID-19 in hospitalised adults.
Read More
Biological E gets drug regulator's approval to conduct phase 2/3 t
Updated : 3 weeks, 3 days ago IST
New Delhi [India], September 2 (ANI): The Drug Controller General of India (DCGI) on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct Phase 2 & 3 clinical trials for its anti-COVID shots called Corbevax on children between 5 and 18 years of age with certain
Read More
Wait for two-three months till children get vaccinated against COV
Updated : 4 weeks ago IST
New Delhi [India], August 29 (ANI): Stating that India approved Zydus Cadila's DNA vaccine for emergency use in adults and children, Medanta Chairman and Managing Director Dr Naresh Trehan on Sunday cautioned against the re-opening of schools and said that since the vaccine is around the
Read More
Enzene Biosciences Ltd. obtains a Marketing Authorization for its
Updated : 1 month ago IST
Pune (Maharashtra) [India], August 27 (ANI/PRNewswire): Enzene Biosciences Ltd. "Enzene" announces a successful Marketing Authorization (MA) from the Drug Controller General of India (DCGI) for its third biosimilar drug 'Denosumab', indicated for the treatment of osteoporosis in adults.
Read More
SEC recommends Phase 1 clinical trials of Reliance's Covid Vaccine
Updated : 1 month ago IST
New Delhi [India], August 27 (ANI): The Subject Expert Committee (SEC) has recommended Phase 1 clinical trials of Reliance's recombinant COVID-19 vaccine candidate.
Read More
Adolescents likely to get ZyCoV-D COVID vaccine after four weeks
Updated : 1 month ago IST
New Delhi [India], August 23 (ANI): The Drugs Controller General of India (DCGI) on Friday approved Zydus Cadila's DNA vaccine for emergency use in adults and children aged 12 years and above.
Read More
Will take another 4-5 months to publish phase 3 trials data of ZyC
Updated : 1 month ago IST
New Delhi [India], August 21 (ANI): Managing Director of Zydus Group Dr Sharvil Patel on Saturday said that his firm will soon apply for the Indian drug regulator's approval to conduct trials of ZyCoV-D on children above 2 years and added that it will take another 4-5 months to publish the p
Read More
India approves Zydus Cadila's ZyCoV-D vaccine for emergency use fo
Updated : 1 month, 1 week ago IST
New Delhi [India], August 20 (ANI): Zydus Cadila's wait for a regulatory nod for its ZyCoV-D plasmid DNA vaccine against Covid is over. The Ahmedabad-based pharma company has received approval from the Drugs Controller General of India (DCGI).
Read More
Enzene Biosciences Ltd. obtains Marketing Authorization for its Ro
Updated : 1 month, 1 week ago IST
Pune (Maharashtra) [India], August 20 (ANI/PRNewswire): Enzene Biosciences Ltd. "Enzene" announces a successful Marketing Authorization (MA) from the Drug Controller General of India (DCGI) for its second biosimilar drug "Romiplostim", indicated for the treatment of chronic Immune Thrombocyt
Read More
Zydus Cadila submits additional data to DCGI for its COVID-19 vacc
Updated : 2 months ago IST
New Delhi [India], July 27 (ANI): Ahmedabad-based Zydus Cadila has submitted additional data related to immunogenicity and safety, on its three-dose COVID-19 vaccine ZyCoV-D, to India's drug regulator Drugs Controller General of India (DCGI), sources said on Tuesday.
Read More
Zydus Cadila expected to provide additional data on Covid-19 vacci
Updated : 2 months, 1 week ago IST
New Delhi [India], July 20 (ANI): Emergency approval for Zydus Cadila's Covid-19 vaccine may take a few more days with the Ahmedabad-based pharma company set to submit additional data related to immunogenicity and safety of its Zycov-D vaccine to the Drugs Controller General of India (DCGI)
Read More